US Patent Issued to DANA-FARBER CANCER INSTITUTE on Oct. 6 for "Cyclin-dependent kinase inhibitors and methods of use" (Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,203, issued on Oct. 6, was assigned to DANA-FARBER CANCER INSTITUTE INC. (Boston).

"Cyclin-dependent kinase inhibitors and methods of use" was invented by Nathanael S. Gray (Boston) and John Hatcher (Malborough, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds of Formula (I) or pharmaceutically acceptable salts thereof are provided and methods involving compounds of Formula (I) as effective inhibitors of CDK8 and/or CDK19 are also provided."

The patent was filed on May 8, 2023, under Application No. 18/144,534.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=...